A two-center comparison of the efficacy of methylene blue and hydroxocobalamin for the treatment of refractory shock
Published online on March 10, 2026
Abstract
Perfusion, Ahead of Print.
BackgroundAlthough methylene blue and hydroxocobalamin are commonly used as rescue treatments for refractory shock, large-scale head-to-head trials comparing these agents are lacking. This study aimed to evaluate their effects on vasopressor doses in ...
BackgroundAlthough methylene blue and hydroxocobalamin are commonly used as rescue treatments for refractory shock, large-scale head-to-head trials comparing these agents are lacking. This study aimed to evaluate their effects on vasopressor doses in ...